Ethmoid sinusitis

Summary

Ethmoid sinusitis (MONDO:0005756) is a disease and 3 clinical trials. A subtype of sinusitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	ethmoid sinusitis
Mondo ID	MONDO:0005756
EFO	EFO:0007264
MeSH	D015521
DOID	DOID:9507
NCIT	C34597
SNOMED CT	18643000
UMLS	C0015029
MedGen	5046
Anatomy (UBERON)	UBERON:0001679
Is cancer (heuristic)	no

Also known as: ethmoid bone sinusitis · ethmoidal sinusitis · sinusitis of ethmoid bone

Disease family

This is a subtype of sinusitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › otorhinolaryngologic disease › nasal disorder › paranasal sinus disorder › sinusitis › ethmoid sinusitis

Related subtypes (4): frontal sinusitis, maxillary sinusitis, sphenoid sinusitis, chronic rhinosinusitis

Subtypes (2): chronic ethmoidal sinusitis, acute ethmoiditis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE4	1
EARLY_PHASE1	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00554190	PHASE4	COMPLETED	Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel
NCT02297243	EARLY_PHASE1	COMPLETED	Sinopsys Lacrimal Stent Indicated for Sinus Irrigation
NCT03304951	Not specified	COMPLETED	Sinopsys® Lacrimal Stent Indicated for Sinus Irrigation